<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The volatile <z:chebi fb="164" ids="38867">anesthetic</z:chebi> <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> is capable of inducing preconditioning and postconditioning effects in the brain </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the effects of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning on <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and immunity indexes in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion (CIR) rats </plain></SENT>
<SENT sid="2" pm="."><plain>Rats were randomly assigned to five separate experimental groups I-V </plain></SENT>
<SENT sid="3" pm="."><plain>In the sham group (I), rats were subjected to the same surgery procedures except for occlusion of the middle cerebral artery and exposed to 1.0 MAC <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> 90 min after surgery for 30 min </plain></SENT>
<SENT sid="4" pm="."><plain>IR control rats (group II) were subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 90 min and exposed to O₂ for 30 min at the beginning of reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> 0.5, 1.0 and 1.5 groups (III, IV, V) were <z:hpo ids='HP_0000001'>all</z:hpo> subjected to MCAO for 90 min, but at the beginning of reperfusion exposed to 0.5 MAC, 1.0 MAC or 1.5 MAC <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> for 30 min, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Results showed that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning can decrease serum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-α), interleukin-1 beta (IL-1β), nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO), nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (NOS) and increase serum interleukin-10 (IL-10) levels in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion rats </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning can still decrease blood <z:chebi fb="23" ids="18059">lipid</z:chebi>, malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) levels, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and increase <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes activities, <z:mpath ids='MPATH_458'>normal</z:mpath> pyramidal neurons density in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion rats </plain></SENT>
<SENT sid="8" pm="."><plain>It can be concluded that <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> postconditioning may decrease blood and brain oxidative injury and enhance immunity indexes in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> reperfusion rats </plain></SENT>
</text></document>